24.10.2013
- Small But Mighty - Highly potent active ingredients (HPAPIs) are remarkably effective at small doses. Therapies including oncology, hormones, narcotics, musculoskeletal treatments...
11.09.2013
- Familiar Face - Michel Spagnol is no stranger to the chemical industry; Novasep's brand-new CEO has held senior-level positions in companies such as Rhodia and Shasun. He brings...
27.06.2013
- Michel Spagnol has been appointed president and CEO of Novasep; he succeeds Patrick Glaser. Spagnol was most recently president and chief technology officer of Shasun; previously...
04.06.2013
- Novasep, a supplier of manufacturing solutions to the life sciences industry, announces it has strengthened its position in the fine chemicals marketplace with the appointment of...
28.05.2013
- Responsibility - As the chemical industry evolves into the world's solution providers for modern global challenges, its obligation to adhere to sustainable principles and practices...
29.01.2013
- A Look into the Future - Where is the U.S. economy heading in 2013? Industry leaders predict their companies will navigate uncertainty, including changes in pharmaceutical...
25.09.2012
- A Spoonful of Safety - Demand in the pharmaceutical industry has sharply increased for the manufacture of targeted and potent drugs that improve efficacy and reduce side effects...
10.08.2012
- Novasep, a supplier of manufacturing solutions to the life sciences industries, announces today a €3 million investment to expand its Highly Potent API (HPAPI) manufacturing...
